Value of pre-implantation genetic testing questioned

Dr Karin Hammarberg

writer

Dr Karin Hammarberg

Senior Research Fellow, Global and Women’s Health, School of Public Health & Preventive Medicine, Monash University

David Amor

writer

David Amor

Lorenzo and Pamela Galli Chair in Developmental Medicine, Murdoch Children’s Research Institute

Claim CPD for this activity

Educational Activities (EA)
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)
0 minutes

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)
0 minutes

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

If you’re going through IVF, you may be offered a test to look at your embryos’ chromosomes.

Pre-implantation genetic testing for aneuploidy (chromosome abnormalities), known as PGT-A, is an “add on” used to help choose embryos with the right number of chromosomes. It’s promoted by IVF clinics as a way to increase the chance of success, especially for women over 35.

But the evidence shows that in most cases, PGT-A doesn’t improve the chance of a baby.

What is aneuploidy?

Human cells usually contain 46 chromosomes. Aneuploidy is a term that describes a chromosome number that is different from 46 – either too many or too few chromosomes.

In human embryos, most aneuploidies are lethal, resulting in miscarriage, or do not result in pregnancy at all.

The chance of aneuploidy increases with the age of the woman; by the time a woman reaches age 40, approximately 80% of her embryos are aneuploid.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Peter Wong

Prof Peter Wong

Fracture Prevention and Osteoporosis Management After Menopause

Dr Richard Symes

Dr Richard Symes

Ophthalmology Update: New Treatments for Old Conditions

Prof Bu Yeap

Prof Bu Yeap

Testosterone for Men – Common Myths and Recent Development

Dr Victoria Hayes

Dr Victoria Hayes

Conversation Strategies for Unfunded Vaccinations

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Karin Hammarberg

writer

Dr Karin Hammarberg

Senior Research Fellow, Global and Women’s Health, School of Public Health & Preventive Medicine, Monash University

David Amor

writer

David Amor

Lorenzo and Pamela Galli Chair in Developmental Medicine, Murdoch Children’s Research Institute

Test your knowledge

Recent articles

Latest GP poll

In general, do you support allowing non-GPs to refer to specialists in certain situations?

Yes, if the referral process involves meaningful collaboration with GPs

0%

Yes

0%

No

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.